08:00 , Dec 16, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Psoriasis TRAF3 interacting protein 2 (TRAF3IP2; ACT1); inducible nitric oxide synthase 2 (NOS2; iNOS); F-box and leucine-rich repeat protein 19...